Background Malignant pleural effusions (MPE) are a frequent cause of dyspnea and
discomfort at the end of cancer patients' lives. The tunneled indwelling pleural catheter …

Malignant pleural effusions (MPEs) are an important complication for patients with
intrathoracic and extrathoracic malignancies. Median survival after diagnosis of an MPE is 4 …

Context Malignant pleural effusion causes disabling dyspnea in patients with a short life
expectancy. Palliation is achieved by fluid drainage, but the most effective first-line method …

Introduction Malignant pleural effusions (MPEs) are a common cause of dyspnea in patients
with advanced cancer. Tunnelled pleural catheters (TPCs) can be used in patients with this …

Background Malignant pleural effusions (MPEs) affect> 150,000 people each year in the
United States. Current palliative options include pleurodesis and placement of an indwelling …

Malignant pleural effusions (MPEs) complicate the clinical course of patients with a broad
array of malignancies, which are most often due to lymphomas or carcinomas of the breast …

Abstract Introduction: Malignant pleural effusions (MPEs) complicate many advanced
malignancies and the median prognosis for those who develop MPEs is 6 months. These …

Malignant pleural effusion (MPE) is a known complication of both thoracic and extra thoracic
malignancies. The presence of MPE regardless of the primary site translates into advanced …

Abstract Roughly 150,000 malignant pleural effusions (MPE) are diagnosed in the United
States each year. The majority of cases are caused by lung and breast cancer, and since …

Qualitätsindikatoren wurden durch Sens et al. wie folgt definiert:„Ein Indikator ist ein
quantitatives Maß, welches zum Monitoring und zur Bewertung der Qualität wichtiger …